+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antibody Production Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables, Software), By Type, By Process, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2023
  • Region: Global
  • Grand View Research
  • ID: 5830938
Description Jump to:
The global antibody production market size is anticipated to reach USD 42.86 billion by 2030. The market is expected to expand at a CAGR of 12.92% from 2023 to 2030. Due to the rising incidence of chronic illnesses such as cancer, diabetes, and cardiovascular diseases, as well as the increased need for therapeutic antibodies the antibody production market is anticipated a significant growth.

Nearly half of all R&D programs related to monoclonal antibodies are allocated for cancer treatment. The focused approach of monoclonal antibodies has transformed cancer treatment by minimizing adverse effects and enhancing patient outcomes. Nevertheless, further research and development are crucial to maximize the effectiveness of antibodies in treating cancer. The market for antibody production is anticipated to experience growth due to the escalated investment in research and development activities, particularly in cancer treatment. Moreover, the demand for personalized medicine, which seeks to offer customized treatments based on an individual's genetic composition, lifestyle, and environmental influences, is anticipated to boost the antibody production market's growth.

The antibody production market was greatly influenced by the COVID-19 pandemic due to the increasing popularity of common laboratory tests like immunohistochemistry, cell imaging, and western blot analysis for diagnosis. Additionally, with the urgent need for therapeutic antibodies and vaccines to combat the virus, there has been a surge in demand for antibody production services. However, disruptions in the global supply chain and manufacturing processes caused by lockdowns, travel restrictions, and workforce shortages have posed significant challenges to the market's growth. Despite the challenges, the antibody production market has demonstrated resilience, and many companies have adapted their operations to continue serving customers during the pandemic.

Furthermore, the antibody production market is expected to grow due to the increasing demand for personalized medicine, which aims to provide tailored treatments based on an individual's genetic makeup, lifestyle, and environmental factors. Monoclonal antibodies are essential tools in personalized medicine, as they can be designed to target specific disease-causing proteins or cells. The growing demand for personalized medicine is expected to further drive the growth of the antibody production market. Additionally, the rise in the approval of antibodies for the treatment of cancer and various diseases is also contributing to market growth, as demonstrated by the U. S. FDA's emergency use authorization (EUA) for a monoclonal antibody, bebtelovimab, which retains activity against the omicron variant and is used for the treatment of COVID-19.

Antibody Production Market Report Highlights

  • Based on product, the consumables segment dominated in terms of the revenue share of 55.93% in 2022. This is attributed to growing demand for antibodies for study, diagnostics, and therapeutics, which has steered to a corresponding rise in the demand for consumables
  • Based on process, the downstream segment dominated in terms of the revenue share of 67.04% in 2022 owing to the various technological advancements supporting the downstream process to maintain efficiency, thus, fueling innovations in bio-manufacturing, and hence, increasing the demand for the process in the antibody production market
  • In 2022, North America dominated with a revenue share of 38.29%, owing to the rising investments in drug discovery, growing developments in biopharmaceutical research, and the presence of major key players are anticipated to drive the growth of the antibody production market in this region
  • Asia Pacific accounted for the fastest-growing region with a CAGR of 16.13% from 2023 to 2030. The growing investments in R&D activities and the increasing prevalence of chronic diseases are driving the rising demand for the antibody production market in this region
  • Based on type, the monoclonal antibodies segment dominated in terms of the revenue share of 63.25% in 2022 owing to the growing demand for biologics, primarily due to the increasing incidence of chronic diseases like cancer, and cardiovascular diseases, among others. Thus, increasing the demand for the monoclonal antibodies in the market.
  • Based on end use, the pharmaceutical and biotechnology companies segment dominates in terms of the revenue share of 55.06% in 2022. The expanding use of antibodies in the production processes of biopharmaceutical companies is considered one of the primary factors driving the growth of this segment

Table of Contents

Chapter 1. Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.1.1 Product Segment
1.1.1.2 Process Segment
1.1.1.3 Type Segment
1.1.1.4 End Use Segment
1.2 Information Procurement
1.2.1 Market Formulation & Data Visualization
1.2.2 Data Validation & Publishing
1.3 Research Assumptions
1.4 Research Methodology
1.4.1 Purchased Database
1.4.2 Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.5 Details Of Primary Research
1.5 Information Or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.1.1 Approach 1: Commodity flow approach
1.8 List of Secondary Sources
1.9 Global Market: CAGR Calculation
1.10 Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Antibody Production Market Variables and Trends
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Impact Analysis
3.2.1.1. Increased Demand For Therapeutic Antibodies
3.2.1.2. Increasing Investment In R&D
3.2.1.3. Rise In Adoption Of Antibody Production For Personalized Medicine And Companion Diagnostics
3.2.2. Market Restraint Impact Analysis
3.2.2.1. Stringent Government Regulations
3.3. Penetration And Growth Prospect Mapping 2022
3.4. Business Environment Analysis
3.4.1. Swot Analysis; By Factor (Political & Legal, Economic And Technological)
3.4.2. Porter’s Five Forces Analysis
3.5. Covid-19 Impact Analysis
Chapter 4. Antibody Production Market: Product Estimates & Trend Analysis
4.1. Product Movement Analysis & Market Share, 2022 & 2030
4.2. Antibody Production Market Estimates & Forecast, By Product (USD Million)
4.3. Instruments
4.3.1. Global Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Bioreactors
4.3.2.1. Global Bioreactors Market Estimates and Forecasts, 2018 - 2030 (USD Millions)
4.3.2.2. Multi-use Bioreactor
4.3.2.2.1. Global Multi-Use Bioreactors Market Estimates and Forecasts, 2018 - 2030 (USD Millions)
4.3.2.3. Single-use Bioreactor
4.3.2.3.1. Global Single-Use Bioreactors Market Estimates and Forecasts, 2018 - 2030 (USD Millions)
4.3.3. Chromatography Systems
4.3.3.1. Global Chromatography Systems Market Estimates and Forecasts, 2018 - 2030 (USD Millions)
4.3.4. Filtration Systems
4.3.4.1. Global Filtration Systems Market Estimates and Forecasts, 2018 - 2030 (USD Millions)
4.4. Consumables
4.4.1. Global Consumables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Media
4.4.2.1. Global Media Market Estimates and Forecasts, 2018 - 2030 (USD Millions)
4.4.3. Buffers and Reagents
4.4.3.1. Global Buffers and Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Millions)
4.4.4. Chromatography Resins and Columns
4.4.4.1. Global Chromatography Resins and Columns Market Estimates and Forecasts, 2018 - 2030 (USD Millions)
4.4.5. Filtration Consumables and Accessories
4.4.5.1. Global Filtration Consumables and Accessories Market Estimates and Forecasts, 2018 - 2030 (USD Millions)
4.4.6. Others
4.4.6.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Millions)
4.5. Software
4.5.1. Global Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Antibody Production Market: Process Estimates & Trend Analysis
5.1. Process Movement Analysis & Market Share, 2022 & 2030
5.2. Antibody Production Market Estimates & Forecast, By Process (USD Million)
5.3. Upstream Processing
5.3.1. Global Upstream Processing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Downstream Processing
5.4.1. Global Downstream Processing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Antibody Production Market: Type Estimates & Trend Analysis
6.1. Type Movement Analysis & Market Share, 2022 & 2030
6.2. Antibody Production Market Estimates & Forecast, By Type (USD Million)
6.3. Monoclonal Antibody
6.3.1. Global Monoclonal Antibody Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Polyclonal Antibody
6.4.1. Global Polyclonal Antibody Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Antibody Production Market: End Use Estimates & Trend Analysis
7.1. End Use Movement Analysis & Market Share, 2022 & 2030
7.2. Antibody Production Market Estimates & Forecast, By End Use (USD Million)
7.3. Pharmaceutical and Biotechnology Companies
7.3.1. Global Pharmaceutical and Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Research Laboratories
7.4.1. Global Research Laboratories Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. CROs and CDMOs
7.5.1. Global CROs and CDMOs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Antibody Production Market: Regional Estimates & Trend Analysis
8.1. Antibody Production Market: Region Outlook
8.2. North America
8.2.1. NORTH AMERICA ANTIBODY PRODUCTION MARKET ESTIMATES AND FORECASTS, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. Key country dynamics
8.2.2.2. Competitive scenario
8.2.2.3. Regulatory scenario
8.2.2.4. U.S. antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Key country dynamics
8.2.3.2. Competitive scenario
8.2.3.3. Regulatory scenario
8.2.3.4. Canada antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe Antibody Production market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. Key country dynamics
8.3.2.2. Competitive scenario
8.3.2.3. Regulatory scenario
8.3.2.4. UK antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Key country dynamics
8.3.3.2. Competitive scenario
8.3.3.3. Regulatory scenario
8.3.3.4. Germany antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. Key country dynamics
8.3.4.2. Competitive scenario
8.3.4.3. Regulatory scenario
8.3.4.4. France antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Key country dynamics
8.3.5.2. Competitive scenario
8.3.5.3. Regulatory scenario
8.3.5.4. Italy antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Key country dynamics
8.3.6.2. Competitive scenario
8.3.6.3. Regulatory scenario
8.3.6.4. Spain antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Key country dynamics
8.3.7.2. Competitive scenario
8.3.7.3. Regulatory scenario
8.3.7.4. Denmark antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Key country dynamics
8.3.8.2. Competitive scenario
8.3.8.3. Regulatory scenario
8.3.8.4. Sweden antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Key country dynamics
8.3.9.2. Competitive scenario
8.3.9.3. Regulatory scenario
8.3.9.4. Norway antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Antibody Production market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.2. China
8.4.2.1. Key country dynamics
8.4.2.2. Competitive scenario
8.4.2.3. Regulatory scenario
8.4.2.4. China antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.3. Japan
8.4.3.1. Key country dynamics
8.4.3.2. Competitive scenario
8.4.3.3. Regulatory scenario
8.4.3.4. Japan antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. Key country dynamics
8.4.4.2. Competitive scenario
8.4.4.3. Regulatory scenario
8.4.4.4. India antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.5. South Korea
8.4.5.1. Key country dynamics
8.4.5.2. Competitive scenario
8.4.5.3. Regulatory scenario
8.4.5.4. South Korea antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.6. Australia
8.4.6.1. Key country dynamics
8.4.6.2. Competitive scenario
8.4.6.3. Regulatory scenario
8.4.6.4. Australia antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Key country dynamics
8.4.7.2. Competitive scenario
8.4.7.3. Regulatory scenario
8.4.7.4. Thailand antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Antibody Production market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Key country dynamics
8.5.2.2. Competitive scenario
8.5.2.3. Regulatory scenario
8.5.2.4. Brazil antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key country dynamics
8.5.3.2. Competitive scenario
8.5.3.3. Regulatory scenario
8.5.3.4. Mexico antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.5.4. Argentina
8.5.4.1. Key country dynamics
8.5.4.2. Competitive scenario
8.5.4.3. Regulatory scenario
8.5.4.4. Argentina antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.6. MEA
8.6.1. MEA Antibody Production market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. Key country dynamics
8.6.2.2. Competitive scenario
8.6.2.3. Regulatory scenario
8.6.2.4. South Africa antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key country dynamics
8.6.3.2. Competitive scenario
8.6.3.3. Regulatory scenario
8.6.3.4. Saudi Arabia antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. Key country dynamics
8.6.4.2. Competitive scenario
8.6.4.3. Regulatory scenario
8.6.4.4. UAE antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key country dynamics
8.6.5.2. Competitive scenario
8.6.5.3. Regulatory scenario
8.6.5.4. Kuwait antibody production market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Participant Categorization
9.1.1. Illumina, Inc.
9.1.1.1. Overview
9.1.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.1.3. Product Benchmarking
9.1.1.4. Strategic Initiatives
9.1.2. Thermo Fisher Scientific, Inc.
9.1.2.1. Overview
9.1.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.2.3. Product Benchmarking
9.1.2.4. Strategic Initiatives
9.1.3. Pacific Biosciences of California, Inc.
9.1.3.1. Overview
9.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.3.3. Product Benchmarking
9.1.3.4. Strategic Initiatives
9.1.4. BGI
9.1.4.1. Overview
9.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.4.3. Product Benchmarking
9.1.4.4. Strategic Initiatives
9.1.5. QIAGEN
9.1.5.1. Overview
9.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.5.3. Product Benchmarking
9.1.5.4. Strategic Initiatives
9.1.6. Agilent Technologies
9.1.6.1. Overview
9.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.6.3. Product Benchmarking
9.1.6.4. Strategic Initiatives
9.1.7. PerkinElmer, Inc.
9.1.7.1. Overview
9.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.7.3. Product Benchmarking
9.1.7.4. Strategic Initiatives
9.1.8. ProPhase Labs, Inc.
9.1.8.1. Overview
9.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.8.3. Product Benchmarking
9.1.8.4. Strategic Initiatives
9.1.9. Psomagen
9.1.9.1. Overview
9.1.9.2. Product Benchmarking
9.1.9.3. Strategic Initiatives
9.1.10. Azenta US, Inc.
9.1.10.1. Overview
9.1.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.1.10.3. Product Benchmarking
9.1.10.4. Strategic Initiatives
9.2. Participant’s Overview
9.3. Financial Performance
9.4. Product Benchmarking
9.5. Company Market Share Analysis, 2022
9.6. Strategy Mapping
9.6.1. Expansion
9.6.2. Acquisition
9.6.3. Collaborations
9.6.4. Partnerships
9.6.5. Product/service launch
9.6.6. Others
List of Tables
Table 1 List of Abbreviations
Table 2 Global antibody production market, by product, 2018 - 2030 (USD Million)
Table 3 Global antibody production market, by process, 2018 - 2030 (USD Million)
Table 4 Global antibody production market, by type, 2018 - 2030 (USD Million)
Table 5 Global antibody production market, by end use, 2018 - 2030 (USD Million)
Table 6 Global antibody production market, by region, 2018 - 2030 (USD Million)
Table 7 North America antibody production market, by country, 2018 - 2030 (USD Million)
Table 8 North America antibody production market, by product, 2018 - 2030 (USD Million)
Table 9 North America antibody production market, by process, 2018 - 2030 (USD Million)
Table 10 North America antibody production market, by type, 2018 - 2030 (USD Million)
Table 11 North America antibody production market, by end use, 2018 - 2030 (USD Million)
Table 12 U.S. antibody production market, by product, 2018 - 2030 (USD Million)
Table 13 U.S. antibody production market, by process, 2018 - 2030 (USD Million)
Table 14 U.S. antibody production market, by type, 2018 - 2030 (USD Million)
Table 15 U.S. antibody production market, by end use, 2018 - 2030 (USD Million)
Table 16 Canada antibody production market, by product, 2018 - 2030 (USD Million)
Table 17 Canada antibody production market, by process, 2018 - 2030 (USD Million)
Table 18 Canada antibody production market, by type, 2018 - 2030 (USD Million)
Table 19 Canada antibody production market, by end use, 2018 - 2030 (USD Million)
Table 20 Europe antibody production market, by country, 2018 - 2030 (USD Million)
Table 21 Europe antibody production market, by product, 2018 - 2030 (USD Million)
Table 22 Europe antibody production market, by process, 2018 - 2030 (USD Million)
Table 23 Europe antibody production market, by type, 2018 - 2030 (USD Million)
Table 24 Europe antibody production market, by end use, 2018 - 2030 (USD Million)
Table 25 Germany antibody production market, by product, 2018 - 2030 (USD Million)
Table 26 Germany antibody production market, by process, 2018 - 2030 (USD Million)
Table 27 Germany antibody production market, by type, 2018 - 2030 (USD Million)
Table 28 Germany antibody production market, by end use, 2018 - 2030 (USD Million)
Table 29 UK antibody production market, by product, 2018 - 2030 (USD Million)
Table 30 UK antibody production market, by process, 2018 - 2030 (USD Million)
Table 31 UK antibody production market, by type, 2018 - 2030 (USD Million)
Table 32 UK antibody production market, by end use, 2018 - 2030 (USD Million)
Table 33 France antibody production market, by product, 2018 - 2030 (USD Million)
Table 34 France antibody production market, by process, 2018 - 2030 (USD Million)
Table 35 France antibody production market, by type, 2018 - 2030 (USD Million)
Table 36 France antibody production market, by end use, 2018 - 2030 (USD Million)
Table 37 Italy antibody production market, by product, 2018 - 2030 (USD Million)
Table 38 Italy antibody production market, by process, 2018 - 2030 (USD Million)
Table 39 Italy antibody production market, by type, 2018 - 2030 (USD Million)
Table 40 Italy antibody production market, by end use, 2018 - 2030 (USD Million)
Table 41 Spain antibody production market, by product, 2018 - 2030 (USD Million)
Table 42 Spain antibody production market, by process, 2018 - 2030 (USD Million)
Table 43 Spain antibody production market, by type, 2018 - 2030 (USD Million)
Table 44 Spain antibody production market, by end use, 2018 - 2030 (USD Million)
Table 45 Denmark antibody production market, by product, 2018 - 2030 (USD Million)
Table 46 Denmark antibody production market, by process, 2018 - 2030 (USD Million)
Table 47 Denmark antibody production market, by type, 2018 - 2030 (USD Million)
Table 48 Denmark antibody production market, by end use, 2018 - 2030 (USD Million)
Table 49 Sweden antibody production market, by product, 2018 - 2030 (USD Million)
Table 50 Sweden antibody production market, by process, 2018 - 2030 (USD Million)
Table 51 Sweden antibody production market, by type, 2018 - 2030 (USD Million)
Table 52 Sweden antibody production market, by end use, 2018 - 2030 (USD Million)
Table 53 Norway antibody production market, by product, 2018 - 2030 (USD Million)
Table 54 Norway antibody production market, by process, 2018 - 2030 (USD Million)
Table 55 Norway antibody production market, by type, 2018 - 2030 (USD Million)
Table 56 Norway antibody production market, by end use, 2018 - 2030 (USD Million)
Table 57 Asia Pacific antibody production market, by country, 2018 - 2030 (USD Million)
Table 58 Asia Pacific antibody production market, by product, 2018 - 2030 (USD Million)
Table 59 Asia Pacific antibody production market, by process, 2018 - 2030 (USD Million)
Table 60 Asia Pacific antibody production market, by type, 2018 - 2030 (USD Million)
Table 61 Asia Pacific antibody production market, by end use, 2018 - 2030 (USD Million)
Table 62 China antibody production market, by product, 2018 - 2030 (USD Million)
Table 63 China antibody production market, by process, 2018 - 2030 (USD Million)
Table 64 China antibody production market, by type, 2018 - 2030 (USD Million)
Table 65 China antibody production market, by end use, 2018 - 2030 (USD Million)
Table 66 Japan antibody production market, by product, 2018 - 2030 (USD Million)
Table 67 Japan antibody production market, by process, 2018 - 2030 (USD Million)
Table 68 Japan antibody production market, by type, 2018 - 2030 (USD Million)
Table 69 Japan antibody production market, by end use, 2018 - 2030 (USD Million)
Table 70 India antibody production market, by product, 2018 - 2030 (USD Million)
Table 71 India antibody production market, by process, 2018 - 2030 (USD Million)
Table 72 India antibody production market, by type, 2018 - 2030 (USD Million)
Table 73 India antibody production market, by end use, 2018 - 2030 (USD Million)
Table 74 South Korea antibody production market, by product, 2018 - 2030 (USD Million)
Table 75 South Korea antibody production market, by process, 2018 - 2030 (USD Million)
Table 76 South Korea antibody production market, by type, 2018 - 2030 (USD Million)
Table 77 South Korea antibody production market, by end use, 2018 - 2030 (USD Million)
Table 78 Australia antibody production market, by product, 2018 - 2030 (USD Million)
Table 79 Australia antibody production market, by process, 2018 - 2030 (USD Million)
Table 80 Australia antibody production market, by type, 2018 - 2030 (USD Million)
Table 81 Australia antibody production market, by end use, 2018 - 2030 (USD Million)
Table 82 Thailand antibody production market, by product, 2018 - 2030 (USD Million)
Table 83 Thailand antibody production market, by process, 2018 - 2030 (USD Million)
Table 84 Thailand antibody production market, by type, 2018 - 2030 (USD Million)
Table 85 Thailand Antibody production market, by end use, 2018 - 2030 (USD Million)
Table 86 Latin America antibody production market, by country, 2018 - 2030 (USD Million)
Table 87 Latin America antibody production market, by product, 2018 - 2030 (USD Million)
Table 88 Latin America antibody production market, by process, 2018 - 2030 (USD Million)
Table 89 Latin America antibody production market, by type, 2018 - 2030 (USD Million)
Table 90 Latin America antibody production market, by end use, 2018 - 2030 (USD Million)
Table 91 Brazil antibody production market, by product, 2018 - 2030 (USD Million)
Table 92 Brazil antibody production market, by process, 2018 - 2030 (USD Million)
Table 93 Brazil antibody production market, by type, 2018 - 2030 (USD Million)
Table 94 Brazil antibody production market, by end use, 2018 - 2030 (USD Million)
Table 95 Mexico antibody production market, by product, 2018 - 2030 (USD Million)
Table 96 Mexico antibody production market, by process, 2018 - 2030 (USD Million)
Table 97 Mexico antibody production market, by type, 2018 - 2030 (USD Million)
Table 98 Mexico antibody production market, by end use, 2018 - 2030 (USD Million)
Table 99 Argentina antibody production market, by product, 2018 - 2030 (USD Million)
Table 100 Argentina antibody production market, by process, 2018 - 2030 (USD Million)
Table 101 Argentina antibody production market, by type, 2018 - 2030 (USD Million)
Table 102 Argentina antibody production market, by end use, 2018 - 2030 (USD Million)
Table 103 Middle East & Africa antibody production market, by product, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa antibody production market, by process, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa antibody production market, by type, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa antibody production market, by end use, 2018 - 2030 (USD Million)
Table 107 South Africa antibody production market, by product, 2018 - 2030 (USD Million)
Table 108 South Africa antibody production market, by process, 2018 - 2030 (USD Million)
Table 109 South Africa antibody production market, by type, 2018 - 2030 (USD Million)
Table 110 South Africa antibody production market, by end use, 2018 - 2030 (USD Million)
Table 111 Saudi Arabia antibody production market, by product, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia antibody production market, by process, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia antibody production market, by type, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia antibody production market, by end use, 2018 - 2030 (USD Million)
Table 115 UAE antibody production market, by product, 2018 - 2030 (USD Million)
Table 116 UAE antibody production market, by process, 2018 - 2030 (USD Million)
Table 117 UAE antibody production market, by type, 2018 - 2030 (USD Million)
Table 118 UAE antibody production market, by end use, 2018 - 2030 (USD Million)
Table 119 Kuwait antibody production market, by product, 2018 - 2030 (USD Million)
Table 120 Kuwait antibody production market, by process, 2018 - 2030 (USD Million)
Table 121 Kuwait antibody production market, by type, 2018 - 2030 (USD Million)
Table 122 Kuwait antibody production market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Antibody production market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
Fig. 13 Porter’s five forces analysis
Fig. 14 Market penetration & growth prospect mapping, 2022
Fig. 15 Global antibody production market: Product movement analysis
Fig. 16 Global antibody production market product outlook: Key takeaways
Fig. 17 Global antibody production market, for instruments, 2018 - 2030 (USD Million)
Fig. 18 Global antibody production market, for bioreactors, 2018 - 2030 (USD Million)
Fig. 19 Global antibody production market, for multi-use bioreactors, 2018 - 2030 (USD Million)
Fig. 20 Global antibody production market, for single-use bioreactors, 2018 - 2030 (USD Million)
Fig. 21 Global antibody production market, for chromatography systems, 2018 - 2030 (USD Million)
Fig. 22 Global antibody production market, for filtration systems, 2018 - 2030 (USD Million)
Fig. 23 Global antibody production market, for consumables, 2018 - 2030 (USD Million)
Fig. 24 Global antibody production market, for media, 2018 - 2030 (USD Million)
Fig. 25 Global antibody production market, for buffers and reagents, 2018 - 2030 (USD Million)
Fig. 26 Global antibody production market, for chromatography resins and columns, 2018 - 2030 (USD Million)
Fig. 27 Global antibody production market, for filtration consumables and accessories, 2018 - 2030 (USD Million)
Fig. 28 Global antibody production market, for others, 2018 - 2030 (USD Million)
Fig. 29 Global antibody production market, for software, 2018 - 2030 (USD Million)
Fig. 30 Global antibody production market: Process movement analysis
Fig. 31 Global antibody production market process outlook: Key takeaways
Fig. 32 Global antibody production market, for upstream processing, 2018 - 2030 (USD Million)
Fig. 33 Global antibody production market, for downstream processing, 2018 - 2030 (USD Million)
Fig. 34 Global antibody production market: Type movement analysis
Fig. 35 Global antibody production market type outlook: Key takeaways
Fig. 36 Global antibody production market, for monoclonal antibody, 2018 - 2030 (USD Million)
Fig. 37 Global antibody production market, for polyclonal antibody, 2018 - 2030 (USD Million)
Fig. 38 Global antibody production market: End use movement analysis
Fig. 39 Global antibody production end use outlook: Key takeaways
Fig. 40 Global Pharmaceutical and biotechnology companies market, 2018 - 2030 (USD Million)
Fig. 41 Global research laboratories market, 2018 - 2030 (USD Million)
Fig. 42 Global CROs and CDMOs market, 2018 - 2030 (USD Million)
Fig. 43 Regional marketplace: key takeaways
Fig. 44 Regional outlook, 2022 & 2030
Fig. 45 Global antibody production market: region movement analysis
Fig. 46 North America antibody production market, 2018 - 2030 (USD Million)
Fig. 47 U.S. antibody production market, 2018 - 2030 (USD Million)
Fig. 48 Canada antibody production market, 2018 - 2030 (USD Million)
Fig. 49 Europe antibody production market, 2018 - 2030 (USD Million)
Fig. 50 Germany antibody production market, 2018 - 2030 (USD Million)
Fig. 51 UK antibody production market, 2018 - 2030 (USD Million)
Fig. 52 France antibody production market, 2018 - 2030 (USD Million)
Fig. 53 Italy antibody production market, 2018 - 2030 (USD Million)
Fig. 54 Spain antibody production market, 2018 - 2030 (USD Million)
Fig. 55 Denmark antibody production market, 2018 - 2030 (USD Million)
Fig. 56 Sweden antibody production market, 2018 - 2030 (USD Million)
Fig. 57 Norway antibody production market, 2018 - 2030 (USD Million)
Fig. 58 Asia Pacific antibody production market, 2018 - 2030 (USD Million)
Fig. 59 Japan antibody production market, 2018 - 2030 (USD Million)
Fig. 60 China antibody production market, 2018 - 2030 (USD Million)
Fig. 61 India antibody production market, 2018 - 2030 (USD Million)
Fig. 62 Australia antibody production market, 2018 - 2030 (USD Million)
Fig. 63 South Korea antibody production market, 2018 - 2030 (USD Million)
Fig. 64 Thailand antibody production market, 2018 - 2030 (USD Million)
Fig. 65 Latin America antibody production market, 2018 - 2030 (USD Million)
Fig. 66 Brazil antibody production market, 2018 - 2030 (USD Million)
Fig. 67 Mexico antibody production market, 2018 - 2030 (USD Million)
Fig. 68 Argentina antibody production market, 2018 - 2030 (USD Million)
Fig. 69 Middle East and Africa antibody production market, 2018 - 2030 (USD Million)
Fig. 70 South Africa antibody production market, 2018 - 2030 (USD Million)
Fig. 71 Saudi Arabia antibody production market, 2018 - 2030 (USD Million)
Fig. 72 UAE antibody production market, 2018 - 2030 (USD Million)
Fig. 73 Kuwait antibody production market, 2018 - 2030 (USD Million)

Companies Mentioned

  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Pacific Biosciences of California, Inc.
  • BGI
  • QIAGEN
  • Agilent Technologies
  • PerkinElmer, Inc.
  • ProPhase Labs, Inc.
  • Psomagen
  • Azenta US, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 16.35 Billion
Forecasted Market Value ( USD ) by 2030 $ 42.86 Billion
Compound Annual Growth Rate12.9%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Antibody Production Market by Antibody Type, Process, End-User - Global Forecast 2025-2030 - Product Image

Antibody Production Market by Antibody Type, Process, End-User - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Monoclonal Antibodies Market by Source Type, Production Type, Indication, End-User - Global Forecast 2025-2030 - Product Image

Monoclonal Antibodies Market by Source Type, Production Type, Indication, End-User - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Cancer Monoclonal Antibodies - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Cancer Monoclonal Antibodies - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Monoclonal Antibody (mABs) Therapeutics Market by Production Method (In-Vitro, In-Vivo), Sources (Human, Chimeric), Route of Administration (Intravenous, Subcutaneous), Therapy (Inflammatory & Autoimmune, Oncology, Hematology) - Forecast to 2029 - Product Image

Monoclonal Antibody (mABs) Therapeutics Market by Production Method (In-Vitro, In-Vivo), Sources (Human, Chimeric), Route of Administration (Intravenous, Subcutaneous), Therapy (Inflammatory & Autoimmune, Oncology, Hematology) - Forecast to 2029

  • Report
  • 351 Pages
  • Global
From
Antibody Production - Global Strategic Business Report - Product Image

Antibody Production - Global Strategic Business Report

  • Report
  • 103 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.